The study, which examined data of patients who received IMV in these countries in 2018, also found that patients in the U.S received IMV at a rate twice that in Canada.
Read full story
Research news
Friday, June 30, 2023 Sunnybrook surgeon and researcher to lead Canadian orthopaedic research community
Dr. Bheeshma Ravi as he was recently inducted as the new president of the Canadian Orthopaedic Research Society.
Read full story
Dr. Bheeshma Ravi as he was recently inducted as the new president of the Canadian Orthopaedic Research Society.
Read full story
Monday, June 26, 2023 Study: ICU ventilator use significantly higher in U.S than in England and Canada
The study, which examined data of patients who received IMV in these countries in 2018, also found that patients in the U.S received IMV at a rate twice that in Canada.
Read full story
The study, which examined data of patients who received IMV in these countries in 2018, also found that patients in the U.S received IMV at a rate twice that in Canada.
Read full story
Tuesday, June 20, 2023 Sunnybrook’s Medventions program expands to Atlantic Canada with the Nova Scotia Health Innovation Hub
Today, Sunnybrook Research Institute (SRI) and INOVAIT are proud to announce the expansion of Medventions, Sunnybrook’s flagship fellowship training program in health technology innovation. The program is launching its second Canadian site in Nova Scotia, led by the Nova Scotia Health Innovation Hub in Halifax.
Read full story
Today, Sunnybrook Research Institute (SRI) and INOVAIT are proud to announce the expansion of Medventions, Sunnybrook’s flagship fellowship training program in health technology innovation. The program is launching its second Canadian site in Nova Scotia, led by the Nova Scotia Health Innovation Hub in Halifax.
Read full story
Wednesday, June 14, 2023 Congratulations Dr. Dennis Ko!
Dr. Ko has been appointment as Vice Chair of the Institute Advisory Board, CIHR Institute of Circulatory and Respiratory Health (CIHR-ICRH).
Read full story
Dr. Ko has been appointment as Vice Chair of the Institute Advisory Board, CIHR Institute of Circulatory and Respiratory Health (CIHR-ICRH).
Read full story
Monday, June 5, 2023 Drug prolongs time before brain tumour grows back
As part of the Phase 3 clinical trial, research participants with low-grade gliomas, taking the drug vorasidenib remained free from tumour re-growth for 27.7 months, as of the time of study read-out.
Read full story
As part of the Phase 3 clinical trial, research participants with low-grade gliomas, taking the drug vorasidenib remained free from tumour re-growth for 27.7 months, as of the time of study read-out.
Read full story
